Press

AseBio showcases strategic capacity of Spanish biotechnology industry at Transfiere

16/02/2023

Healthcare · Climate change · Agrifood · International · Financing

• The forum is held in Malaga with over 3,000 professionals from the science and innovation sector. AseBio is displaying innovative bioproducts from over a dozen member companies that are tackling the green transition, as well as hosting a panel discussion to highlight the work being done in the biotechnology industry to drive cutting-edge healthcare and reinforce the National Health System 

AseBio

#11F: AseBio launches first programme to pair female professionals and students in Spanish biotechnology sector

14/02/2023

Services · Talento

• For International Day of Women and Girls in Science, 14 women from 12 companies will host young female students to encourage them to go into science and innovation and show them the different professional careers available in the biotech industry

AseBio

AseBio and Biocat present BIOSPAIN 2023 in Barcelona, with greatest potential of all 20 editions

17/01/2023

Access to innovation · International · BioSpain

• BIOSPAIN 2023 expects to bring together over 1,500 professionals from 30 countries around the world in Barcelona, opening up business opportunities with more than 2,000 one-to-one meetings and 50 investors from Spain and abroad.
• Barcelona, the leader in the biotechnology and life sciences sector in Spain, will host this edition from 26 to 28 September, which is the 20th anniversary of the event.
• During the presentation, AseBio, Biocat, the Government of Catalonia and the Barcelona City Council highlighted the urgent need for a greater commitment to the science and innovation generated by biotechnology companies as a way to tackle the challenges of the future, such as antimicrobial resistance, the ageing population and climate change.

AseBio

AseBio closes out year with 1,000 lines of research registered

15/12/2022

Healthcare · Agrifood · Industrial biotechnology

• 86.6% of studies under way focus on improving people’s health and nearly 14% on protecting the planet. Of all these innovations, 203 are already available on the market or ready for exploitation
• Of all these innovations, a total of 203 are ready for exploitation or available on the market.
• However, 88% of the national companies' biomedicine research pipelines are still in the early stages. 

AseBio

Las soluciones biotecnológicas se abren paso ante el desafío climático y energético

17/11/2022

Climate change · Agrifood · Industrial biotechnology

• AseBio and FUNDECYT-PCTEx are holding the fifth edition of the Green Innovation Forum in Mérida, Extremadura.
• More than 300 experts from the Spanish biotechnology sector have gathered to promote a new model of economic growth marked by the green transition. 

AseBio

Group of experts proposes actions to boost use of new technologies in biotechnology sector

14/11/2022

Digitalization

• AseBio and ASD present in Madrid the document with the main conclusions on the state of new technologies in the industry. 
• One of the proposals for action is to train professionals and develop a strategy for their implementation and permanence over time.

AseBio

More than 100 experts meet at the ISCIII to promote advanced therapies in Spain

20/10/2022

Healthcare · Advanced therapies

• AseBio and CIBER connect academic research with the industrial capabilities of Spanish biotechnology
• Spain ranks 5th in the number of scientific publications in the field of advanced therapies. AseBio has 34 companies with 12 industrial plants throughout Spain.
• The company Lentistem Biotech received the first AseBio-Merck "Advanced Therapies Start-up Competition" award, which was presented at the end of the day.

AseBio

Genomics is positioning itself as a key tool for cancer diagnosis and treatment

21/09/2022

Healthcare · Personalized medicine

• AseBio and Illumina have brought together legislators, clinicians, researchers and biotech companies at the Instituto de Salud Carlos III to promote personalised and precision medicine in oncology.
• Cancer has been the main research area among AseBio members for more than 15 years, with almost 350 open lines of treatment and diagnosis.

AseBio

AseBio y Biovegen se unen para impulsar un cambio de legislación de las nuevas técnicas genómicas

12/07/2022

Agrifood

• Las dos principales asociaciones del sector biotecnológico agroalimentario español invitan a las empresas a participar en la consulta pública de la Comisión Europea

AseBio